Publications by authors named "Colin D Mansfield"

Claim this Profile
T
Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.
Olivier Hermine, Laurent Gros, Truong-An Tran, Lamya Loussaief, Kathleen Flosseau, Colin D Mansfield

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
Albert C Ludolph, Philippe Corcia, Claude Desnuelle, Terry Heiman-Patterson, Jesus S Mora, Colin D Mansfield

Muscle Nerve· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial.
Bruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Colin D Mansfield

Alzheimers Res Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial.
Bruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Colin D Mansfield

Alzheimers Res Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial.
Lavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, Vikranth Deshmukh, Lesia Kuryk, Colin D Mansfield

J Asthma Allergy· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival analysis of masitinib in amyotrophic lateral sclerosis.
Jesus S Mora, Walter G Bradley, Delia Chaverri, María Hernández-Barral, Javier Mascias, Colin D Mansfield

Ther Adv Neurol Disord· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
Jesus S Mora, Angela Genge, Adriano Chio, Conrado J Estol, Delia Chaverri, Colin D Mansfield

Amyotroph Lateral Scler Frontotemporal Degener· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to glass microstructuring techniques.
Radoslaw Mazurczyk, Colin D Mansfield

Methods Mol Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glass microstructure capping and bonding techniques.
Radoslaw Mazurczyk, Colin D Mansfield, Marcin Lygan

Methods Mol Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
Sophie Georgin-Lavialle, Ludovic Lhermitte, Felipe Suarez, Ying Yang, Sébastien Letard, Colin D Mansfield

Eur J Haematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.
Carle Paul, Beatrix Sans, Felipe Suarez, Philippe Casassus, Stéphane Barete, Colin D Mansfield

Am J Hematol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Colin D Mansfield

Arthritis Res Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.
Martine Humbert, Nathalie Castéran, Sébastien Letard, Katia Hanssens, Juan Iovanna, Colin D Mansfield

PLoS One· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib for the treatment of canine atopic dermatitis: a pilot study.
Jenise Daigle, Alain Moussy, Colin D Mansfield, Olivier Hermine

Vet Res Commun· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Patrice Dubreuil, Sébastien Letard, Marco Ciufolini, Laurent Gros, Martine Humbert, Colin D Mansfield

PLoS One· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grafting of antibodies inside integrated microfluidic-microoptic devices by means of automated microcontact printing.
Elie Bou Chakra, Benjamin Hannes, Julien Vieillard, Colin D Mansfield, Radoslav Mazurczyk

Sens Actuators B Chem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new instrument for automated microcontact printing with stamp load adjustment.
Elie Bou Chakra, Benjamin Hannes, Gilles Dilosquer, Colin D Mansfield, Michel Cabrera

Rev Sci Instrum· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of static thermal and near-infrared hyperspectral imaging for the diagnosis of acute maxillary rhinosinusitis.
Colin D Mansfield, E Michael Attas, Richard M Gall

J Otolaryngol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laminar fluid diffusion interface preconditioning of serum and urine for reagent-free infrared clinical analysis and diagnostics.
Colin D Mansfield, Angela Man, Sarah Low-Ying, R Anthony Shaw

Appl Spectrosc· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis